BioLineRx , a biopharmaceutical development company, announced today that it has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd. , the leading Chinese pharmaceutical company in the liver disease therapeutic area, for the development and commercialization of BL-8030, an orally available treatment for the ... (more)
http://www.drugs.com/clinical_trials/biolinerx-enters-into-collaboration-develop-commercialize-hepatitis-c-cttq-15706.html?
http://www.drugs.com/clinical_trials/biolinerx-enters-into-collaboration-develop-commercialize-hepatitis-c-cttq-15706.html?
No comments:
Post a Comment